雲南建投混凝土(01847.HK)持續簽訂玉溪高鐵新城建設項目混凝土供應合同
格隆匯4月15日丨雲南建投混凝土(01847.HK)發佈公告,集團持續簽訂玉溪高鐵新城建設項目混凝土供應合同。本項目位於雲南省玉溪市中心城區西側,可開發用地約為4,539畝,初步測算混凝土總用量約為113萬立方米。本項目預計分三期進行開發,包含玉溪市紅塔區政府公共管理與公共服務項目(城市展廳、政務綜合服務中心、公園、醫院及學校等)及相關住宅、商業配套設施。
截至本公告日期,集團已就本項目一期中的玉溪錦府‧春和、玉溪錦府‧景明及城市展廳3個子項目簽訂混凝土供應合同,合同金額合計約為人民幣1.78億元,涉及混凝土需求量約為50.3萬立方米,預計將於2020年底完工。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.